PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
3979429-4	1985	The inhibitory effects of (+)3-PPP on both transmitter and alpha-MSH release were antagonized by the selective D-2 receptor antagonist (-)-sulpiride.	Sulpiride	135-148	proopiomelanocortin	Rattus norvegicus	59-68	
2540019-4	1989	Sulpiride, a D2-dopamine receptor antagonist, at a concentration of 10(-6) M, induced a significant (P less than 0.05) increase of both basal and potassium-stimulated alpha-MSH release to 203 +/- 21% and 447 +/- 88% of basal release in normal ACSF respectively.	Sulpiride	0-9	proopiomelanocortin	Rattus norvegicus	167-176	
15519677-12	2004	The D2R blockade by sulpiride increased POMC mRNA levels in the hypothalamus, indicating that D2R exerts a tonic inhibitory effect on hypothalamic POMC gene expression.	Sulpiride	20-29	proopiomelanocortin	Rattus norvegicus	40-44	
15519677-12	2004	The D2R blockade by sulpiride increased POMC mRNA levels in the hypothalamus, indicating that D2R exerts a tonic inhibitory effect on hypothalamic POMC gene expression.	Sulpiride	20-29	proopiomelanocortin	Rattus norvegicus	147-151	
7518029-2	1994	In the pituitary, haloperidol and sulpiride induced similar increases of mRNAs of pro-opiomelanocortin (POMC) (+65% and +73%), prolactin (PRL) (+821% and +840%) and growth hormone (GH) (+32% and +47%), but sulpiride induced a greater increase of D2R mRNA (+125%) than haloperidol (+92%).	Sulpiride	34-43	proopiomelanocortin	Rattus norvegicus	82-102	
7518029-2	1994	In the pituitary, haloperidol and sulpiride induced similar increases of mRNAs of pro-opiomelanocortin (POMC) (+65% and +73%), prolactin (PRL) (+821% and +840%) and growth hormone (GH) (+32% and +47%), but sulpiride induced a greater increase of D2R mRNA (+125%) than haloperidol (+92%).	Sulpiride	34-43	proopiomelanocortin	Rattus norvegicus	104-108